Liposomal Doxorubicin
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of a Two-week Dosing Regimen of Vinorelbine Combined with Liposomal Doxorubicin in the Treatment of HER2-negative Advanced Breast Cancer (NCT06653972) | Wang Jiayu | 2024-11-01 |
| Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen (NCT05731258) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-05-01 |
| Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment. (NCT07120217) | Federico II University | 2008-01-01 |
Track Liposomal Doxorubicin automatically
Every clearance here is in the API, with alerts when new ones post.